Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by FredTheVoiceon Mar 15, 2018 2:34pm

156 Views

Post# 27722110

Thanks to Candide

One thing is sure, you made money with THERA, you sold after approval. And, you didn't made unanimity on this board. But who does in life ?

I was happy about all you questions and all the exchanges that it created on this board. I think, you builded some confidence on the way for approval, and you were very surprise by the BUMP on march 6 and 7. I imagined you looking above with gratitude.That is why I wonder if you made the right choice of selling off. My opinion is that 300% is very good, but missing the next wave up.....completely is not a good move. But its your call.

Take care.

FTV.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?